The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer-Reference-Cited by-同舟云学术

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer

Published:2018-04-12 Issue:7 Volume:25 Page:1239-1258
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Fernandez Harvey R.,Gadre Shreyas M.,Tan Mingjun,Graham Garrett T.^ORCID,Mosaoa Rami,Ongkeko Martin S.,Kim Kyu Ah,Riggins Rebecca B.^ORCID,Parasido Erika,Petrini Iacopo^ORCID,Pacini Simone^ORCID,Cheema Amrita,Varghese Rency,Ressom Habtom W,Zhang Yuwen,Albanese Christopher,Üren Aykut,Paige Mikell,Giaccone Giuseppe,Avantaggiati Maria Laura

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-018-0101-z.pdf

Reference54 articles.

1. Thomas A, Liu SV, Subramaniam DS, Giaccone G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol. 2015;12:511–26.

2. Subramaniam DS, Liu SV, Giaccone G. Novel approaches in cancer immunotherapy. Discov Med. 2016;21:267–74.

3. Gower A, Wang Y, Giaccone G. Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer. J Mol Med (Berl). 2014;92:697–707.

4. Niederst MJ, Engelman JA, Hata AN. Distinct evolutionary paths to TKI resistance in NSCLC. Cell Cycle. 2016:1–2. https://doi.org/10.1080/15384101.2016.1221024

5. Thomas A, Giaccone G. Why has active immunotherapy not worked in lung cancer? Ann Oncol. 2015;26:2213–20.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting mitochondrial citrate shuttling induces hepatic triglyceride deposition in Nile tilapia (Oreochromis niloticus) through lipid anabolic remodeling;The Journal of Nutritional Biochemistry;2024-09

2. Inhibition of mitochondrial citrate shuttle alleviates metabolic syndromes induced by high-fat diet;American Journal of Physiology-Cell Physiology;2024-09-01

3. Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy;Nature Communications;2024-07-09

4. Gastric adenocarcinoma predictive long intergenic noncoding RNA (GAPLINC) promotes oral cancer stemness by acting as a molecular sponge of miR331-3p;Journal of Dental Sciences;2024-07

5. ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05